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Abstract
Pseudoangiomatous stromal hyperplasia (PASH) is a benign mesenchymal proliferative lesion
of the breast, often an incidental finding on breast biopsy specimens and rarely presents as a
palpable lump. The case being reported is interesting as a lactating female presented with gross
left breast enlargement due to a huge firm mass with skin thickening and palpable left axillary
lymph nodes. A provisional diagnosis of left breast malignancy was made and the patient
extensively worked up with ultrasound, CT scan, bone scan and core biopsy. The
histopathology, however, revealed PASH of the breast. There was no invasive or in situ
malignancy. The patient was successfully managed conservatively.
Categories: Obstetrics/Gynecology, Pathology, Radiology
Keywords: breast, ultrasound, malignancy, pseudoangiomatous stromal hyperplasia, palpable lump,
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Introduction
Pseudoangiomatous stromal hyperplasia (PASH) of the breast, as the name suggests, is a
benign process which on histology typically consists of anastomosing slit-like spaces within a
background of dense fibrous stroma [1]. It is a usually a coexistent finding on histological
examination of breast biopsy specimens and presentation as a palpable lump is rare. Since the
first case reported in 1986 by Vuitch et al., approximately 150 cases of tumorous PASH have
been reported in the literature [1,2]. The etiology of PASH is not clearly elucidated, but
according to most investigators it represents a proliferative response of myofibroblasts under
the influence of hormonal stimuli [3]. It, therefore, most commonly presents in premenopausal
or perimenopausal women and may also be encountered in postmenopausal women receiving
hormone replacement therapy [4]. Tumorous PASH presents as a slow-growing mass, with an
average size of less than 7 cm and the clinical and radiologic features often suggest an alternate
more common diagnoses, such as fibroadenoma, phyllodes tumor or hamartoma requiring
histopathological confirmation [5,6]. As association with malignancy or malignant
transformation is very rare, smaller incidental lesions may be periodically imaged to assess
interval growth while surgical excision is reserved for larger symptomatic lesions [6].
Case Presentation
A 30-year-old lactating female presented to the breast surgery clinic with a complaint of left
breast heaviness and gradual enlargement since one year. Physical examination revealed gross
asymmetric left breast enlargement with an ill-defined palpable lump measuring approximately
12 x 4.6 cm. There was overlying skin thickening with induration, although no redness and a
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palpable left axillary lymph node. As the patient was lactating, she initially underwent bilateral
breast ultrasound, which showed a large circumscribed mass, wider than tall without any
posterior acoustic shadowing predominantly in upper outer quadrant of the left breast with few
intralesional cystic spaces showing mild vascularity on color Doppler and an abnormal left
axillary lymph node (Figure 1).
FIGURE 1: Gray scale ultrasound image of left breast and axilla
(A) Image shows a solid, circumscribed mass (thin white arrows) predominantly in upper outer
quadrant of left breast with few cystic spaces (curved arrow). (B) Image shows abnormal left
axillary lymph node with asymmetric cortical thickening (short thick arrow) and displaced hilum.
The short axis of the lymph node measured 12 mm and the cortical thickness 8 mm with
compressed fatty hilum. A breast imaging-reporting and data system (BI-RADS) category 4
assessment was given, and biopsy of the lesion and the axillary lymph node was recommended.
The patient was electively admitted for ultrasound-guided core biopsy, blood workup, CT chest,
abdomen and pelvis scan, and bone scintigraphy for metastatic disease. Contrast-enhanced CT
of the chest, abdomen and pelvis showed edematous left breast parenchyma with a large well-
defined solid enhancing lesion associated with overlying skin thickening (Figure 2).
FIGURE 2: Contrast-enhanced CT scan
Axial (A) and coronal (B) images show large enhancing soft tissue mass in the left breast (thick
white arrows). Marked skin thickening is also noted (long white arrow) as well as left breast edema.
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Multiple enlarged left axillary lymph nodes were also noted associated with perinodal
fuzziness. There was no visceral metastasis on CT scan. Whole-body skeletal scintigraphy was
also negative for bony metastasis. On histopathology, the core specimen from left breast lesion
revealed benign breast tissue exhibiting adenosis, stromal sclerosis and pseudovascular
proliferation of mammary stroma delineated by endothelial cells without atypia, features
representing PASH (Figure 3).
FIGURE 3: Photomicrograph (H&E and immunohistochemical
stain)
(A) Linear cores of benign breast tissue exhibiting ducts and lobule with surrounding hyalinized
stroma (arrows. (B) Slit-like spaces mimicking thin blood vessels frequently seen in stroma
(arrows). (C) These spaces are line by bland spindle shape cells (arrow). (D) The lining
cells demonstrate positive expression for CD-34 immunohistochemical stain.
There was no evidence of ductal carcinoma in situ (DCIS) or malignancy. Core specimen from
the left axillary lymph node showed benign lymphoid tissue exhibiting sinus histiocytosis and
acute on chronic inflammation.
The patient received lactation suppression drug (bromocriptine) and anti-hormonal therapy
comprising tamoxifen, and she showed significant clinical improvement.
Discussion
PASH is a benign entity characterized by a network of anastomosing slit-like spaces lined by
spindle-shaped cells in a background of dense, collagenous proliferating breast stroma [2,3]. A
proposed etiology is that this lesion is an abnormal response to progesterone and estrogen
leading to myofibroblast proliferation; hence, it is more commonly seen in premenopausal or
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perimenopausal women and postmenopausal women on hormone replacement therapy [4,7].
PASH can be incidentally found in biopsy specimens performed for other breast lesions. They
have very low mitotic index and rarely manifest as a symptomatic lesion, most cases being
incidentally detected on imaging [8,9]. When symptomatic, the clinical presentation may range
from a single firm, mobile, lump to multiple nodules in about two-third of cases [2,3,8-11]. The
imaging appearances often simulate other common benign tumors, such as fibroadenoma or
phyllodes. Because of considerable overlap of imaging features, the definitive diagnosis is
established on histopathology [9].
On mammography, the most common appearance is a high-density, circumscribed, non-
calcified mass. Suspicious features such as architectural distortion and spiculated margins are
exceptionally rare [8,9,12] . On ultrasound, PASH is usually seen as a well-defined hypoechoic
solid mass. Rarely, it may have a heterogeneous appearance with some cystic areas [13]. Our
patient had well-circumscribed mass with smooth margins on ultrasound with few cleft-like
anechoic cystic areas; however, large size, skin thickening and enlarged axillary lymph nodes
were suspicious for malignancy and prompted extensive workup. Mammography was not
performed as the patient was lactating.
On MRI, tumorous PASH may appear as a well-defined lesion showing gradual progressive
enhancement on post-contrast sequences mimicking fibroadenoma [4]. Non-mass
enhancement is rarely reported [13]. Such enhancement may simulate DCIS requiring biopsy to
confirm this benign entity, especially in high-risk patients.
The definitive diagnosis is established on biopsy. The histological features of PASH may be
confused with low-grade angiosarcoma; however, angiosarcoma shows anastomosing spaces
filled with red blood cells invading the adjacent breast parenchyma and the absence of
collageneous stroma, unlike PASH [6,11]. The hallmark of PASH is dense stromal proliferation
with multiple slit-like spaces lined by bland spindle-shaped cells mimicking tiny blood vessels.
Also, the proliferating myofibroblasts show positive expression of CD34 immunohistochemical
stain in PASH [6]. This feature was also observed in our case. 
The treatment of PASH may be either surgical or non-surgical. Surgery is usually reserved for
large symptomatic lesions with pain or enlargement [3,4,14]. As malignant transformation is
extremely rare, serial imaging follow-up for few years can be considered for cases that are
small, incidentally discovered or when it is asymptomatic [4,6,9]. Given the possible etiological
role of hormones, anti-hormonal therapy can also be considered as an alternative non-invasive
approach in the management of tumor-forming PASH [14]. Our patient did not opt for surgery.
She was prescribed lactation suppression drug as she was lactating along with tamoxifen and
pain medication, and the lesion remarkably regressed in size on clinical follow-up. The patient
unfortunately did not have any post-treatment imaging.
Conclusions
PASH is an uncommon histologic finding in breast biopsy specimens, often an incidental
discovery. Uncommonly, it may present as a palpable breast mass and be indistinguishable from
other benign breast masses. Rarely, it may attain a size or clinical appearance where it may be
confused with malignancy. A core needle biopsy confirms the diagnosis. Large symptomatic
masses may require excision. Some cases, which are hormone responsive, may benefit from
conservative management.
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